Similarly, the MP6 gene set which contains S100A8/A9 downstream of SpHK1/S1P/S1PRs has the potential to serve as a predictive marker for cervical cancer response to immune checkpoint blockers. The gene discussed is S100A8; the disease is cervical carcinoma.